V VALERIO THERAPEUTICS
LIVE

Serial Number

98036044

Owner

VALERIO THERAPEUTICS

Attorney

Ben Natter

Filing Date

Jun 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

V VALERIO THERAPEUTICS Trademark

Serial Number: 98036044 • Registration: 7593772

V VALERIO THERAPEUTICS is a trademark filed by VALERIO THERAPEUTICS on June 9, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VALERIO THERAPEUTICS (2 trademarks)

49 BOULEVARD DU GÉNÉRAL MARTIAL VALIN
PARIS 75015 , FR

Entity Type: 33

Trademark Details

Filing Date

June 9, 2023

Registration Date

December 10, 2024

Published for Opposition

September 10, 2024

Goods & Services

Pharmaceutical preparations and substances for the treatment of oncological diseases and related immune disorders; Biological preparations for use in medicinal tests for identifying and treating oncological diseases, inoculations being vaccines, and treatment of oncological diseases; medicinal and biological preparations for pharmaceutical use for the treatment of oncological diseases and disorders; Anti-cancer drugs; Pharmaceutical compounds for treating cancer; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Immunoassay reagents for medical use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders

medical analysis services for cancer diagnosis and prognosis; Providing cancer screening services; Medical analysis services for the diagnosis of cancer

Scientific, medical and pharmaceutical research for the treatment of oncological diseases; research and development of pharmaceutical preparations in the field of oncological diseases and disorders; drug discovery services for the treatment of oncological and immune related diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Pharmaceutical products development; Clinical research in the field of oncology; Provision of information and data relating to medical research and development of pharmaceutical products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2024 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 5, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2024 CRFA
ASSIGNED TO LIE
Aug 4, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 2, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 18, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2023 NWOS